نتائج البحث

Early monitoring of infliximab serum trough levels predicts long-term therapy failure in patients with axial spondyloarthritis.

• Authors : Martínez-Feito, A^1,2 (AUTHOR) ; Navarro-Compán, V^2,3 (AUTHOR); Hernández-Breijo, B² (AUTHOR)

• Source: Scandinavian Journal of Rheumatology. Mar2022, Vol. 51 Issue 2, p102-109. 8p.

تفاصيل العنوان

No preventive or therapeutic efficacy of infliximab against macrophage activation syndrome due to systemic juvenile idiopathic arthritis.

• Authors : Kiuchi Z; a Department of Nephrology and Rheumatology , National Center for Child Health and Development , Tokyo , Japan.; b Department of Paediatrics , Kyorin University School of Medicine , Tokyo , Japan.

Subjects: Immunoglobulins, Intravenous*/Immunoglobulins, Intravenous*/Immunoglobulins, Intravenous*/administration & dosage ; Immunoglobulins, Intravenous*/Immunoglobulins, Intravenous*/Immunoglobulins, Intravenous*/immunology ; Infliximab*/Infliximab*/Infliximab*/administration & dosage

• Source: Scandinavian journal of rheumatology [Scand J Rheumatol] 2019 May; Vol. 48 (3), pp. 246-248. Date of Electronic Publication: 2018 Nov 08.Publisher: Informa Healthcare Country of Publication: England NLM ID: 0321213 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Pretreatment resistin levels are associated with erosive disease in early rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs and infliximab.

• Authors : Vuolteenaho, K¹ (AUTHOR); Tuure, L¹ (AUTHOR); Nieminen, R¹ (AUTHOR)

• Source: Scandinavian Journal of Rheumatology. May2022, Vol. 51 Issue 3, p180-185. 6p.

تفاصيل العنوان

Association of female sex and positive rheumatoid factor with low serum infliximab and anti-drug antibodies, related to treatment failure in early rheumatoid arthritis: results from the SWEFOT trial population.

• Authors : Hambardzumyan K; Hermanrud C ...

Subjects: Antibodies/Antibodies/Antibodies/*blood ; Arthritis, Rheumatoid/Arthritis, Rheumatoid/Arthritis, Rheumatoid/*drug therapy ; Infliximab/Infliximab/Infliximab/*pharmacokinetics

• Source: Scandinavian journal of rheumatology [Scand J Rheumatol] 2019 Sep; Vol. 48 (5), pp. 362-366. Date of Electronic Publication: 2019 Jun 27.Publisher: Informa Healthcare Country of Publication: England NLM ID: 0321213 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Concentrations of infliximab and anti-drug antibodies in relation to clinical response in patients with rheumatoid arthritis.

• Authors : Siljehult F; a Department of Public Health and Clinical Medicine/Rheumatology , Umeå University , Umeå , Sweden.; Ärlestig L

Subjects: Antibodies/Antibodies/Antibodies/*blood ; Antirheumatic Agents/Antirheumatic Agents/Antirheumatic Agents/*blood ; Arthritis, Rheumatoid/Arthritis, Rheumatoid/Arthritis, Rheumatoid/*drug therapy

• Source: Scandinavian journal of rheumatology [Scand J Rheumatol] 2018 Sep; Vol. 47 (5), pp. 345-350. Date of Electronic Publication: 2018 Apr 27.Publisher: Informa Healthcare Country of Publication: England NLM ID: 0321213 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care.

• Authors : Glintborg B; a The Danish Rheumatologic Biobank, the DANBIO Registry and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics , Rigshospitalet , Glostrup , Denmark.; b Department of Rheumatology, Gentofte and Herlev Hospital , Copenhagen University Hospital , Gentofte , Denmark.

Subjects: Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*blood ; Arthritis/Arthritis/Arthritis/*drug therapy ; Infliximab/Infliximab/Infliximab/*administration & dosage

• Source: Scandinavian journal of rheumatology [Scand J Rheumatol] 2018 Sep; Vol. 47 (5), pp. 418-421. Date of Electronic Publication: 2018 Jan 09.Publisher: Informa Healthcare Country of Publication: England NLM ID: 0321213 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

The cost-effectiveness of infliximab in the treatment of ankylosing spondylitis in Spain. Comparison of clinical trial and clinical practice data.

• Authors : Kobelt, G.^1,2 (AUTHOR) ; Sobocki, P.³ (AUTHOR); Mulero, J.⁴ (AUTHOR)

• Source: Scandinavian Journal of Rheumatology. Jan2008, Vol. 37 Issue 1, p62-71. 10p. 1 Diagram, 3 Charts, 4 Graphs.

تفاصيل العنوان

The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review.

• Authors : Kristensen, L. E.¹ (AUTHOR) ; Christensen, R.² (AUTHOR); Bliddal, H.² (AUTHOR)

• Source: Scandinavian Journal of Rheumatology. Dec2007, Vol. 36 Issue 6, p411-417. 7p. 1 Diagram, 2 Charts.

تفاصيل العنوان

Infliximab dosage and infusion frequency in clinical practice: experiences in the Stockholm biologics registry STURE.

• Authors : van Vollenhoven, R. F.¹ (AUTHOR) ; Klareskog, L.¹ (AUTHOR)

• Source: Scandinavian Journal of Rheumatology. Dec2007, Vol. 36 Issue 6, p418-423. 6p. 2 Charts, 1 Graph.

تفاصيل العنوان

Effects of infliximab on cytokines, myeloperoxidase, and soluble adhesion molecules in patients with juvenile idiopathic arthritis.

• Authors : Levälampi, T.^1,2 (AUTHOR); Honkanen, V.³ (AUTHOR); Lahdenne, P.³ (AUTHOR)

• Source: Scandinavian Journal of Rheumatology. May2007, Vol. 36 Issue 3, p189-193. 5p. 2 Charts, 1 Graph.

تفاصيل العنوان